Ethinylestradiol/cyproterone acetate

From WikiMD's WELLNESSPEDIA

(Redirected from Juliet-35)

Ethinylestradiol/cyproterone acetate is a combination of ethinylestradiol, an estrogen, and cyproterone acetate, an antiandrogen and progestogen. It is an oral contraceptive that is used widely in the treatment of androgen-dependent conditions like acne, seborrhea, hirsutism, and androgenic alopecia in women.

Etymology[edit]

The term "ethinylestradiol" is derived from the words "ethynyl" and "estradiol". "Ethynyl" refers to the presence of a triple bond between two carbon atoms, while "estradiol" is a type of estrogen, a hormone that plays a key role in the female reproductive system. "Cyproterone acetate" is named after its two components: "cyproterone", an antiandrogen and progestogen, and "acetate", a salt or ester of acetic acid.

Pharmacology[edit]

Ethinylestradiol is a synthetic estrogen that is more potent than natural estrogens. It works by inhibiting the release of gonadotropins, which in turn prevents ovulation. Cyproterone acetate is a derivative of progesterone and has antiandrogenic properties. It works by blocking the effects of androgens in the body, which can help to reduce symptoms of androgen-dependent conditions.

Uses[edit]

Ethinylestradiol/cyproterone acetate is primarily used as an oral contraceptive. It is also used in the treatment of androgen-dependent conditions in women, such as acne, seborrhea, hirsutism, and androgenic alopecia. In addition, it can be used in the treatment of polycystic ovary syndrome (PCOS), a condition characterized by high levels of androgens and irregular menstrual periods.

Side Effects[edit]

Like all medications, ethinylestradiol/cyproterone acetate can cause side effects. These may include nausea, vomiting, headache, breast tenderness, changes in menstrual periods, and mood changes. In rare cases, it can cause serious side effects such as blood clots, liver problems, and allergic reactions.

See Also[edit]


Ethinylestradiol/cyproterone_acetate[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.